---
title: 'Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian
  Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy'
date: '2024-04-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38675779/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240428181100&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Ovarian cancer is one of the most common cancers among women and the
  most lethal malignancy of all gynecological cancers. Surgery is promising in the
  early stages; however, most patients are first diagnosed in the advanced stages,
  where treatment options are limited. Here, we present a 49-year-old patient who
  was first diagnosed with stage III ovarian cancer. After the tumor progressed several
  times under guideline therapies with no more treatment options available at that
  time, the ...
disable_comments: true
---
Ovarian cancer is one of the most common cancers among women and the most lethal malignancy of all gynecological cancers. Surgery is promising in the early stages; however, most patients are first diagnosed in the advanced stages, where treatment options are limited. Here, we present a 49-year-old patient who was first diagnosed with stage III ovarian cancer. After the tumor progressed several times under guideline therapies with no more treatment options available at that time, the ...